VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

(3:42)

VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories

(11:33)

VolitionRx Limited Announces Interim Results from a 680-Subject Clinical Trial in Colorectal Cancer

(5:26)

$VNRX VolitionRx Limited Q3 2024 Earnings Conference Call

(52:9)

Revolutionizing Healthcare: The Power of VolitionRX's Nucleosomics Platform

(31)

VolitionRx Limited Full Fiscal Year 2023 Financial Results and Business Update

(12:19)

Revolutionizing the Diagnosis of Life-altering Diseases 為重疾診斷技術帶來革命性突破 | VolitionRx (NYSE-A: VNRX)

(9:26)

VolitionRx on Commercial Launch of Cancer Screen Test for Canines and Veterinary Market Opportunity

(10:3)

VolitionRx – Commercializing the Nu.Q Vet Cancer Test: Webinar

(36:37)

VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update

(1:1econd)

VolitionRx Provides Update on Animal Health Blood Test Program, Licensing Deals and Focus for 2021

(10:16)

VolitionRx Limited 2019 Full Year Earnings Results

(7:12)

VolitionRx Limited February 2021 Diamond Equity Presentation

(26:32)

VolitionRx: Blood tests for cancers

(2:20)

You Need To Pay Attention To Volition Stock NYSE: VNRX

(1:48)

VolitionRx Limited releases prostate cancer data, moving towards larger trials

(4:19)

VolitionRx Limited Full Fiscal Year 2022 Financial Results and Business Update

(12:57)

VolitionRx - 2024 Q3 Earnings Analysis

(5:15)

BMS Is Taking Illegal Gifts | Blue Mountain State

(7:4)

EMMY VOX - IMANA IBIRIMO (Official Video)

(2:24)

Standard Form to Vertex Form - Quadratic Equations

(2:43)

Volition (VNRX) NobleCon18 Presentation Replay

(24:56)

Revolutionizing The Diagnosis of Life-Altering Diseases - VolitionRx Limited. at GCFF Nov 16, 2022

(18:51)